| The status of platinum anticancer drugs in the clinic and in clinical trials NJ Wheate, S Walker, GE Craig, R Oun Dalton transactions 39 (35), 8113-8127, 2010 | 1894 | 2010 |
| The side effects of platinum-based chemotherapy drugs: a review for chemists R Oun, YE Moussa, NJ Wheate Dalton transactions 47 (19), 6645-6653, 2018 | 1499 | 2018 |
| Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin SD Brown, P Nativo, JA Smith, D Stirling, PR Edwards, B Venugopal, ... Journal of the American Chemical Society 132 (13), 4678-4684, 2010 | 989 | 2010 |
| Multi-nuclear platinum complexes as anti-cancer drugs NJ Wheate, JG Collins Coordination chemistry reviews 241 (1-2), 133-145, 2003 | 342 | 2003 |
| The Potential of Cucurbit[n]urils in Drug Delivery S Walker, R Oun, FJ McInnes, NJ Wheate Israel Journal of Chemistry 51 (5‐6), 616-624, 2011 | 313 | 2011 |
| The state-of-play and future of platinum drugs MG Apps, EHY Choi, NJ Wheate Endocrine-related research, 2015 | 308 | 2015 |
| DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis NJ Wheate, CR Brodie, JG Collins, S Kemp, JR Aldrich-Wright Mini reviews in medicinal chemistry 7 (6), 627-648, 2007 | 301 | 2007 |
| Improving platinum (II)-based anticancer drug delivery using cucurbit [n] urils NJ Wheate Journal of inorganic biochemistry 102 (12), 2060-2066, 2008 | 175 | 2008 |
| Multi-nuclear platinum complexes encapsulated in cucurbit [n] uril as an approach to reduce toxicity in cancer treatment J áGrant Collins Chemical communications, 1424-1425, 2004 | 152 | 2004 |
| Cucurbit [n] uril binding of platinum anticancer complexes NJ Wheate, DP Buck, AI Day, JG Collins Dalton transactions, 451-458, 2006 | 151 | 2006 |
| Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields AJ Wagstaff, SD Brown, MR Holden, GE Craig, JA Plumb, RE Brown, ... Inorganica Chimica Acta 393, 328-333, 2012 | 134 | 2012 |
| Multi-nuclear platinum drugs: a new paradigm in chemotherapy NJ Wheate, JG Collins Current Medicinal Chemistry-Anti-Cancer Agents 5 (3), 267-279, 2005 | 134 | 2005 |
| The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles R Oun, RS Floriano, L Isaacs, EG Rowan, NJ Wheate Toxicology research 3 (6), 447-455, 2014 | 119 | 2014 |
| Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect JA Plumb, B Venugopal, R Oun, N Gomez-Roman, Y Kawazoe, ... Metallomics 4 (6), 561-567, 2012 | 117 | 2012 |
| Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? GE Craig, SD Brown, DA Lamprou, D Graham, NJ Wheate Inorganic Chemistry 51 (6), 3490-3497, 2012 | 115 | 2012 |
| Evaluation of anionic half generation 3.5–6.5 poly (amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin GJ Kirkpatrick, JA Plumb, OB Sutcliffe, DJ Flint, NJ Wheate Journal of inorganic biochemistry 105 (9), 1115-1122, 2011 | 111 | 2011 |
| Solid state stabilisation of the orally delivered drugs atenolol, glibenclamide, memantine and paracetamol through their complexation with cucurbit [7] uril FJ McInnes, NG Anthony, AR Kennedy, NJ Wheate Organic & Biomolecular Chemistry 8 (4), 765-773, 2010 | 111 | 2010 |
| Encapsulation of platinum (II)-based DNA intercalators within cucurbit [6, 7, 8] urils S Kemp, NJ Wheate, S Wang, JG Collins, SF Ralph, AI Day, VJ Higgins, ... JBIC Journal of Biological Inorganic Chemistry 12, 969-979, 2007 | 110 | 2007 |
| The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum (II)-based metallointercalators S Kemp, NJ Wheate, DP Buck, M Nikac, JG Collins, JR Aldrich-Wright Journal of inorganic biochemistry 101 (7), 1049-1058, 2007 | 107 | 2007 |
| Studies of the mechanism of action of platinum (II) complexes with potent cytotoxicity in human cancer cells AM Krause-Heuer, R Grünert, S Kühne, M Buczkowska, NJ Wheate, ... Journal of medicinal chemistry 52 (17), 5474-5484, 2009 | 105 | 2009 |
